These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9857358)

  • 21. Discovery of a Novel Mutation (X8Del) Resulting in an 8-bp Deletion in the Hepatitis B Virus X Gene Associated with Occult Infection in Korean Vaccinated Individuals.
    Kim H; Gong JR; Lee SA; Kim BJ
    PLoS One; 2015; 10(10):e0139551. PubMed ID: 26437447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR; Velayati AA; Mamishi S; Nabavi M; Aghakhani A; Bidari-Zerehpoosh F; Haghi Ashtiani MT; Sabeti S; Banifazl M; Azimian-Zavareh F; Motevalli F; Soleymani S; Ramezani A
    Arch Virol; 2016 Dec; 161(12):3405-3411. PubMed ID: 27613286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants.
    Hino K; Katoh Y; Vardas E; Sim J; Okita K; Carman WF
    Vaccine; 2001 Jul; 19(28-29):3912-8. PubMed ID: 11427265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Summaries for patients. Does hepatitis B vaccination protection continue after 15 years?
    Ann Intern Med; 2005 Mar; 142(5):I34. PubMed ID: 15738447
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis B vaccination.
    Romanò L; Paladini S; Galli C; Raimondo G; Pollicino T; Zanetti AR
    Hum Vaccin Immunother; 2015; 11(1):53-7. PubMed ID: 25483515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular evolution of hepatitis B vaccine escape variants in China, during 2000-2016.
    Wang J; Qiu J; Zhu Y; Zhou H; Yu L; Ding Y; Zhang L; Guo Z; Dong C
    Vaccine; 2017 Oct; 35(43):5808-5813. PubMed ID: 28939157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.
    Ogata N; Cote PJ; Zanetti AR; Miller RH; Shapiro M; Gerin J; Purcell RH
    Hepatology; 1999 Sep; 30(3):779-86. PubMed ID: 10462386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naturally occurring hepatitis B virus surface antigen mutant variants in Malaysian blood donors and vaccinees.
    Hudu SA; Harmal NS; Saeed MI; Alshrari AS; Malik YA; Niazlin MT; Hassan R; Sekawi Z
    Eur J Clin Microbiol Infect Dis; 2015 Jul; 34(7):1349-59. PubMed ID: 25792010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HB vaccine escape mutant].
    Homma S
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():51-3. PubMed ID: 15453284
    [No Abstract]   [Full Text] [Related]  

  • 30. Current status of HBV vaccine escape variants--a mathematical model of their epidemiology.
    Wilson JN; Nokes DJ; Carman WF
    J Viral Hepat; 1998 Nov; 5 Suppl 2():25-30. PubMed ID: 9857357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
    Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS
    J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B Virus Immunization Before and After Pediatric Liver Transplantation: Check, Catch-Up, and Check Again!
    L'Huillier AG; McLin VA; Posfay-Barbe KM
    Am J Transplant; 2015 Aug; 15(8):2275-6. PubMed ID: 26014457
    [No Abstract]   [Full Text] [Related]  

  • 33. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
    Tabor E
    J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B vaccination among the Nicobarese tribe: Need to document the impact.
    Murhekar M
    Indian J Med Res; 2015 May; 141(5):662. PubMed ID: 26139786
    [No Abstract]   [Full Text] [Related]  

  • 35. De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody.
    Lu M; Lorentz T
    J Infect Dis; 2003 Apr; 187(8):1323-6. PubMed ID: 12696014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What are the prospects for controlling hepatitis C?
    Klenerman P; Fleming V; Barnes E
    PLoS Med; 2009 Jun; 6(6):e1000096. PubMed ID: 19529757
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine.
    Poland GA; Jacobson RM
    N Engl J Med; 2004 Dec; 351(27):2832-8. PubMed ID: 15625334
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis B vaccination in pregnancy.
    Wood N; Isaacs D
    Expert Rev Vaccines; 2012 Feb; 11(2):125-7. PubMed ID: 22309660
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy.
    Luongo M; Critelli R; Grottola A; Gitto S; Bernabucci V; Bevini M; Vecchi C; Montagnani G; Villa E
    J Clin Virol; 2015 Jan; 62():89-91. PubMed ID: 25542480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.